Aptamers are oligonucleotides or peptide bioreceptors that can selectively bind to specific molecular targets with high affinity. Aptamers have proved to be an excellent alternative to monoclonal antibodies. Due to its properties, aptamers have found application in therapeutic drug development, diagnostics, and biotechnology research and development. Aptamers are non-immunogenic, non-toxic and also have fewer side effects as compared to monoclonal antibodies because of the absence of Fc ... Read more

Aptamers can be generated quickly as compared to antibodies which is a plus point and hence they are used widely in treating diseases. The global aptamers market is expected to witness a probable increase in demand and hence growth which is influenced by factors associated with the aptamer product. The increase in the research and development activities along with increase in the investments in the biotechnological and ... Read more

The global aptamers market growth is influenced by factors such as developments in technology, advancements in the research, coupled with an increase in the investments made in the biopharmaceutical and pharmaceutical companies. The technological developments and patent expiration of SELEX is more likely to push the growth of the global aptamers market. Aptamers can be generated at a very rapid rate than antibodies; this makes them even more useful in treating diseases at a higher speed. ... Read more

The aptamers market is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 18.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Aptamers are short, single-stranded DNA or RNA oligonucleotides that can bind to a specific target molecule. They have wide range of applications in diagnostics, research, ... Read more